FDA Inspection 860079 — Philips North America, LLC

Philips North America, LLC — FEI 1218950

The FDA completed an inspection of Philips North America, LLC on December 12, 2013 in Andover, MA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 12 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
December 12, 2013
Fiscal Year
2014
Product Type
Devices
Project Area
Compliance: Devices
Location
Andover, MA (United States)

Citations

IDCFRDescription
265021 CFR 820.30(f)Design verification - Lack of or inadequate procedures
310121 CFR 820.30(g)Design validation- Lack of or inadequate procedures
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
313021 CFR 820.100(a)Lack of or inadequate procedures
317221 CFR 820.198(c)Investigation of device failures
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
419121 CFR 806.10(a)(1)Report of risk to health
51221 CFR 820.65Traceability Lack of or inadequate {see also 820.120(e)}
73121 CFR 803.50(a)(1)Report of Death or Serious Injury
73221 CFR 803.50(a)(2)Individual Report of Malfunction
74521 CFR 803.52(b)(2)Death